Your browser doesn't support javascript.
loading
[Which side effects should I inform patients about?] / Over welke bijwerkingen informeer ik de patiënt?
Reumerman, M O; van Puijenbroek, E P; Janson, J M; van Agtmael, M A.
Afiliação
  • Reumerman MO; Amsterdam UMC, locatie VUmc, afd. Interne Geneeskunde.
  • van Puijenbroek EP; Contact: M. O. Reumerman (m.reumerman@amsterdamumc.nl).
  • Janson JM; Rijksuniversiteit Groningen, faculteit Farmacie.
  • van Agtmael MA; Koninklijke Nederlandsche Maatschappij tot bevordering der Geneeskunst (KNMG), Utrecht.
Ned Tijdschr Geneeskd ; 1642020 07 30.
Article em Nl | MEDLINE | ID: mdl-32757513
ABSTRACT
The law requires that healthcare professionals adequately inform patients about possible side effects when they prescribe new pharmacological treatments. There are several reasons (lack of time, fear of nocebo effect, patient and prescriber preferences) why informing patients in detail could be undesirable or even harmful. Prescribers should focus on two types of side effects (a) common side effects with significant impact on the quality of life and (b) side effects that should be recognised in time to prevent further harm. During treatment, patients should be monitored regularly for efficacy and side effects in order to weigh benefits and risks and to stop or switch therapy when necessary.
Assuntos
Buscar no Google
Base de dados: MEDLINE Assunto principal: Pacientes / Médicos / Educação de Pacientes como Assunto / Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos / Farmacovigilância Idioma: Nl Ano de publicação: 2020 Tipo de documento: Article
Buscar no Google
Base de dados: MEDLINE Assunto principal: Pacientes / Médicos / Educação de Pacientes como Assunto / Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos / Farmacovigilância Idioma: Nl Ano de publicação: 2020 Tipo de documento: Article